Search research articles
Contact Us
Filters
Showing results (1-10 of 36) with videos related to
Page
of 4
Sort By:
Advances in Cancer Research
|
November 3, 2009
Clusterin and chemoresistance
Julie Y Djeu, Sheng Wei
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 16, 2002
A view to a kill: signals triggering cytotoxicity
Julie Y Djeu, Kun Jiang, Sheng Wei
Cancer Research
|
June 5, 2007
Mechanism and therapeutic reversal of immune suppression in cancer
Donna L Herber, Srinivas Nagaraj, Julie Y Djeu, et al.
Cancer Research
|
January 17, 2009
Advances and challenges in basic and translational research on clusterin
Ioannis P Trougakos, Julie Y Djeu, Efstathios S Gonos, et al.
Molecular and Cellular Biology
|
June 1, 2004
Akt mediates Ras downregulation of RhoB, a suppressor of transformation, invasion, and metastasis
Kun Jiang, Jiazhi Sun, Jin Cheng, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 13, 2010
A novel chemoimmunomodulating property of docetaxel: suppression of myeloid-derived suppressor cells in tumor bearers
Krithika N Kodumudi, Karrune Woan, Danielle L Gilvary, et al.
Molecular Cancer Therapeutics
|
November 21, 2007
Clusterin mediates TRAIL resistance in prostate tumor cells
David A Sallman, Xianghong Chen, Bin Zhong, et al.
Blood
|
October 24, 2002
Regulation of Akt-dependent cell survival by Syk and Rac
Kun Jiang, Bin Zhong, Connie Ritchey, et al.
The Journal of Biological Chemistry
|
January 10, 2002
Regulation of the mitogen-activated protein kinase signaling pathway by SHP2
Jess M Cunnick, Songshu Meng, Yuan Ren, et al.
Scientific Reports
|
October 16, 2015
HMGB1 induction of clusterin creates a chemoresistant niche in human prostate tumor cells
Junmin Zhou, Xianghong Chen, Danielle L Gilvary, et al.
Page
of 4
Search research articles
Search
Showing results (1-10 of 36) with videos related to
Sort By:
Page
of 4
Advances in Cancer Research
|
November 3, 2009
Clusterin and chemoresistance
Julie Y Djeu, Sheng Wei
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 16, 2002
A view to a kill: signals triggering cytotoxicity
Julie Y Djeu, Kun Jiang, Sheng Wei
Cancer Research
|
June 5, 2007
Mechanism and therapeutic reversal of immune suppression in cancer
Donna L Herber, Srinivas Nagaraj, Julie Y Djeu, et al.
Cancer Research
|
January 17, 2009
Advances and challenges in basic and translational research on clusterin
Ioannis P Trougakos, Julie Y Djeu, Efstathios S Gonos, et al.
Molecular and Cellular Biology
|
June 1, 2004
Akt mediates Ras downregulation of RhoB, a suppressor of transformation, invasion, and metastasis
Kun Jiang, Jiazhi Sun, Jin Cheng, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 13, 2010
A novel chemoimmunomodulating property of docetaxel: suppression of myeloid-derived suppressor cells in tumor bearers
Krithika N Kodumudi, Karrune Woan, Danielle L Gilvary, et al.
Molecular Cancer Therapeutics
|
November 21, 2007
Clusterin mediates TRAIL resistance in prostate tumor cells
David A Sallman, Xianghong Chen, Bin Zhong, et al.
Blood
|
October 24, 2002
Regulation of Akt-dependent cell survival by Syk and Rac
Kun Jiang, Bin Zhong, Connie Ritchey, et al.
The Journal of Biological Chemistry
|
January 10, 2002
Regulation of the mitogen-activated protein kinase signaling pathway by SHP2
Jess M Cunnick, Songshu Meng, Yuan Ren, et al.
Scientific Reports
|
October 16, 2015
HMGB1 induction of clusterin creates a chemoresistant niche in human prostate tumor cells
Junmin Zhou, Xianghong Chen, Danielle L Gilvary, et al.
Page
of 4